These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21321209)

  • 1. Alloreactivity is limited by the endogenous peptide repertoire.
    Morris GP; Ni PP; Allen PM
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3695-700. PubMed ID: 21321209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of T-cell alloreactivity.
    Felix NJ; Allen PM
    Nat Rev Immunol; 2007 Dec; 7(12):942-53. PubMed ID: 18007679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.
    Danska JS; Livingstone AM; Paragas V; Ishihara T; Fathman CG
    J Exp Med; 1990 Jul; 172(1):27-33. PubMed ID: 1694219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular constraints on CDR3 for thymic selection of MHC-restricted TCRs from a random pre-selection repertoire.
    Lu J; Van Laethem F; Bhattacharya A; Craveiro M; Saba I; Chu J; Love NC; Tikhonova A; Radaev S; Sun X; Ko A; Arnon T; Shifrut E; Friedman N; Weng NP; Singer A; Sun PD
    Nat Commun; 2019 Mar; 10(1):1019. PubMed ID: 30833553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CDR3 sequences and distal V gene residues in regulating TCR-MHC contacts and ligand specificity.
    Stadinski BD; Trenh P; Duke B; Huseby PG; Li G; Stern LJ; Huseby ES
    J Immunol; 2014 Jun; 192(12):6071-82. PubMed ID: 24813203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of an oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC/peptide complex.
    Steinle A; Reinhardt C; Jantzer P; Schendel DJ
    J Exp Med; 1995 Feb; 181(2):503-13. PubMed ID: 7836907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic Origins of T Cell Receptor Alloreactivity.
    Brzostek J; Gascoigne NRJ
    Transplantation; 2017 Jul; 101(7):1535-1541. PubMed ID: 28114168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4
    Logunova NN; Kriukova VV; Shelyakin PV; Egorov ES; Pereverzeva A; Bozhanova NG; Shugay M; Shcherbinin DS; Pogorelyy MV; Merzlyak EM; Zubov VN; Meiler J; Chudakov DM; Apt AS; Britanova OV
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13659-13669. PubMed ID: 32482872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR.
    Daniel C; Horvath S; Allen PM
    Immunity; 1998 May; 8(5):543-52. PubMed ID: 9620675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of T-cell receptors with a recurrent CDR3β peptide-contact motif within the repertoire of alloreactive CD8(+) T cells.
    Scifo C; Mekaelian L; Munyazesa E; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 2011 Aug; 41(8):2414-23. PubMed ID: 21590766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How an alloreactive T-cell receptor achieves peptide and MHC specificity.
    Wang Y; Singh NK; Spear TT; Hellman LM; Piepenbrink KH; McMahan RH; Rosen HR; Vander Kooi CW; Nishimura MI; Baker BM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4792-E4801. PubMed ID: 28572406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
    Claverie JM; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01.
    Motozono C; Kuse N; Sun X; Rizkallah PJ; Fuller A; Oka S; Cole DK; Sewell AK; Takiguchi M
    J Immunol; 2014 Apr; 192(7):3428-34. PubMed ID: 24600035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: Highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease.
    Morris GP; Allen PM
    J Immunol; 2009 Jun; 182(11):6639-43. PubMed ID: 19454656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
    Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
    J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative theory of affinity-driven T cell repertoire selection.
    Detours V; Mehr R; Perelson AS
    J Theor Biol; 1999 Oct; 200(4):389-403. PubMed ID: 10525398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-TCR ligand binding impacts thymocyte development before αβTCR expression.
    Mallis RJ; Bai K; Arthanari H; Hussey RE; Handley M; Li Z; Chingozha L; Duke-Cohan JS; Lu H; Wang JH; Zhu C; Wagner G; Reinherz EL
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8373-8. PubMed ID: 26056289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity.
    Chen X; Poncette L; Blankenstein T
    J Exp Med; 2017 Nov; 214(11):3417-3433. PubMed ID: 28835417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.